New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
07:33 EDTEBIOEleven Biotherapeutics reports Q1 EPS (80c), may not compare to consensus (39c)
Reports Q1 revenue $0.6M vs. $0 during the same period last year and include amounts from the Thrombogenics collaboration which began in May 2013.
News For EBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
12:21 EDTEBIOEleven Biotherapeutics presents positive Phase 2 clinical data for EBI-005
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use